Form 4: Lb Pharmaceuticals Insider Buys Shares
Insider Transaction (Form 4)
Deep Track Biotechnology Master Fund, Ltd. and 2 others reported changes in beneficial ownership of Lb Pharmaceuticals Inc common stock on July 30, 2026.
Summary
- Open-market purchase: acquired 286,205 Pre-Funded Warrants (Right to Buy) at $34.94 ($9,999,974) on July 30, 2026; holds 664,649 after (Direct).
Sentiment
Score: 9
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $9,999,974, committing personal capital to the stock.
Insider Transactions
Deep Track Biotechnology Master Fund, Ltd. — 10% owner
Deep Track Capital, LP — 10% owner
David Kroin — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-30 | Open-market purchase | Pre-Funded Warrants (Right to Buy) | 286,205 | $35 | $10.0M | 664,649 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-30 | Open-market purchase (286,205 shares) |
Keywords
insider transaction, Form 4, LBRX, LB PHARMACEUTICALS INC, bullish, Deep Track Biotechnology Master Fund, Ltd., Deep Track Capital, LP, David Kroin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.